Linking pages
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2102214 174 comments
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2108891 50 comments
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2108891?query=featured_coronavirus 50 comments
- A new lab study shows troubling signs that Pfizer's and Moderna's COVID-19 shots could be far less effective against the variant first found in South Africa https://uk.news.yahoo.com/pfizer-modernas-covid-19-shots-174512012.html?amp%3Bguce_referrer=ahr0chm6ly9jlm5ld3nub3cuy28udwsv&%3Bguce_referrer_sig=aqaaad4fbndcdhhu59jszrssieiwu5-sbqr-uspmahsrpbh-apl4uypuphfhk7yyxlodacdh_i7y1fjqpk-o0g10c3jxw6t-1-kkkvf7m9cmkttwjqollnittcca_ckkptuuw4zhgfnoapof8dqt6a1i8utbpracllw4pdzz4hfxahqq&guccounter=1 4 comments
- Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum | Nature Communications https://www.nature.com/articles/s41467-021-25479-6 3 comments
- Track COVID-19 Vaccines Advancing Through Clinical Trials | The Scientist Magazine® https://www.the-scientist.com/news-opinion/covid-19-vaccine-frontrunners-67382 3 comments
- Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization | NEJM https://www.nejm.org/doi/full/10.1056/nejmc2103022 3 comments
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant: Cell https://www.cell.com/cell/fulltext/S0092-8674(21)00505-5 0 comments
- Our First Preview of How Vaccines Will Work Against Omicron - The Atlantic https://www.theatlantic.com/science/archive/2021/12/omicron-vaccine-antibodies-neutralization-immunity/620946/ 0 comments
Linked pages
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 1 comment
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2027906 0 comments
- VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208822 0 comments
Related searches:
Search whole site: site:www.nejm.org
Search title: Neutralizing Activity of BNT162b2-Elicited Serum | NEJM
See how to search.